Atomo Diagnostics Ltd
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-Test device; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
Atomo Diagnostics Ltd (AT1) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.145x
Based on the latest financial reports, Atomo Diagnostics Ltd (AT1) has a cash flow conversion efficiency ratio of -0.145x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-962.50K) by net assets (AU$6.64 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Atomo Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Atomo Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Atomo Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Atomo Diagnostics Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bridgeline Digital Inc
NASDAQ:BLIN
|
-0.004x |
|
Leaf Mobile Inc
OTCQB:EAGRF
|
-0.032x |
|
WASHINGTON POST -B-
BE:WPOB
|
0.058x |
|
BP Plastics Holding Bhd
KLSE:5100
|
0.020x |
|
Myotoku Ltd
MU:LXH
|
N/A |
|
BC Technology Group Limited
PINK:BCTCF
|
-0.017x |
|
Media Chinese International Ltd
KLSE:5090
|
-0.030x |
|
Inspirisys Solutions Limited
NSE:INSPIRISYS
|
0.278x |
Annual Cash Flow Conversion Efficiency for Atomo Diagnostics Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of Atomo Diagnostics Ltd from 2017 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$6.98 Million | AU$-1.96 Million | -0.281x | +39.57% |
| 2024-06-30 | AU$10.08 Million | AU$-4.69 Million | -0.465x | -17.53% |
| 2023-06-30 | AU$14.79 Million | AU$-5.85 Million | -0.395x | -249.55% |
| 2022-06-30 | AU$24.81 Million | AU$-2.81 Million | -0.113x | +19.46% |
| 2021-06-30 | AU$30.09 Million | AU$-4.23 Million | -0.140x | +22.67% |
| 2020-06-30 | AU$34.48 Million | AU$-6.26 Million | -0.182x | -154.05% |
| 2019-06-30 | AU$-5.47 Million | AU$-1.84 Million | 0.336x | -70.46% |
| 2018-06-30 | AU$-4.89 Million | AU$-5.56 Million | 1.137x | +101.03% |
| 2017-06-30 | AU$47.82K | AU$-5.26 Million | -109.899x | -- |